Choksi Laboratories

Choksi Laboratories EBITDA per Share

The EBITDA per Share of Choksi Laboratories (526546.BO) as of Oct 27, 2026 is 7.80 INR. In the previous year, EBITDA per Share was 16.13 INR — a change of -51.67% (lower).

EBITDA per Share

7.80INR

YoY

-51.67%

Last updated:

EBITDA per Share of Choksi Laboratories is 2026 7.80 INR. EBITDA per Share of Choksi Laboratories was 2025 16.13 INR. It decreases by -51.67% lower compared to the previous year.

The Choksi Laboratories EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2019
10.43 INR
Jan 1, 2020
1.60 INR
Jan 1, 2021
5.92 INR
Jan 1, 2022
12.79 INR
Jan 1, 2023
17.94 INR
Jan 1, 2024
14.68 INR
Jan 1, 2025
16.13 INR
Jan 1, 2026
7.80 INR
The Choksi Laboratories EBITDA per Share history
YEAREBITDA per ShareYoY
7.80INR-51.67%
16.13INR+9.90%
14.68INR-18.19%
17.94INR+40.24%
12.79INR+116.00%
5.92INR+270.38%
1.60INR-84.67%
10.43INR+14.69%
9.09INR+163.25%
3.45INR-2.56%
3.55INR+6.92%
3.32INR-16.35%
3.96INR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Choksi Laboratories Stock analysis

What does Choksi Laboratories do? Choksi Laboratories Ltd. generates revenue through contract laboratory services for pharmaceuticals, food, agricultural products, construction materials, and chemicals, as well as calibration and validation services for test equipment and process equipment. The company provides environment management services, clinical research, consultancy, and assaying and hallmarking to clients requiring regulatory compliance or analytical testing. Its clients include entities needing pharmaceutical analysis, food and beverage analysis, water analysis, and construction material analysis, alongside those seeking instrument calibration, plant shutdown calibration, and consultancy for in-house calibration laboratories. The firm serves segments such as pharmaceutical manufacturers, food producers, agricultural businesses, construction firms, and environmental management organizations through its comprehensive suite of analytical and calibration solutions. The company's revenue streams include contract laboratory services for pharmaceuticals, food, and agricultural products, alongside calibration services for laboratory and on-site equipment, process equipment, and end-user equipment. Clients utilize these services for regulatory compliance, quality assurance, and operational efficiency, with specific demand from pharmaceutical companies requiring drug testing, food manufacturers needing safety analysis, and construction firms requiring material testing. Choksi Laboratories Ltd. also offers consultancy services for setting up in-house calibration laboratories, catering to organizations aiming to streamline their internal quality control processes. Choksi Laboratories Ltd. delivers analytical testing for pharmaceuticals, food, agricultural products, construction materials, and chemicals, with clients including pharmaceutical manufacturers, food producers, and construction firms. Its calibration services target organizations needing instrument validation and process equipment maintenance, while environment management services support businesses focused on environmental compliance. The company’s consultancy services, including training and third-party inspection, further enhance its offerings for clients requiring specialized expertise in regulatory and quality assurance domains. Choksi Laboratories is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Choksi Laboratories stock

EBITDA per Share of Choksi Laboratories is 7.80 INR in 2026.

EBITDA per Share of Choksi Laboratories changed from 16.13 INR to 7.80 INR, representing a -51.67% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share Choksi Laboratories since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Choksi Laboratories

All Key Metrics — Choksi Laboratories